Commonwealth Equity Services’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $333K | Sell |
66,045
-1,038
| -2% | -$5.23K | ﹤0.01% | 3497 |
|
|
2025
Q1 | $435K | Sell |
67,083
-283
| -0.4% | -$1.84K | ﹤0.01% | 3140 |
|
|
2024
Q4 | $494K | Sell |
67,366
-1,469
| -2% | -$10.8K | ﹤0.01% | 2958 |
|
|
2024
Q3 | $516K | Buy |
68,835
+5,600
| +9% | +$42K | ﹤0.01% | 2869 |
|
|
2024
Q2 | $563K | Sell |
63,235
-3,083
| -5% | -$27.4K | ﹤0.01% | 2736 |
|
|
2024
Q1 | $672K | Sell |
66,318
-100
| -0.2% | -$1.01K | ﹤0.01% | 2563 |
|
|
2023
Q4 | $668K | Sell |
66,418
-1,024
| -2% | -$10.3K | ﹤0.01% | 2472 |
|
|
2023
Q3 | $632K | Sell |
67,442
-2,342
| -3% | -$21.9K | ﹤0.01% | 2399 |
|
|
2023
Q2 | $1.71M | Hold |
69,784
| – | – | ﹤0.01% | 1734 |
|
|
2023
Q1 | $1.62K | Sell |
69,784
-9,384
| -12% | -$218 | ﹤0.01% | 1691 |
|
|
2022
Q4 | $2M | Sell |
79,168
-6,130
| -7% | -$155K | ﹤0.01% | 1500 |
|
|
2022
Q3 | $1.64M | Buy |
85,298
+523
| +0.6% | +$10.1K | ﹤0.01% | 1558 |
|
|
2022
Q2 | $2.16M | Hold |
84,775
| – | – | 0.01% | 1395 |
|
|
2022
Q1 | $2.18M | Sell |
84,775
-845
| -1% | -$21.7K | 0.01% | 1445 |
|
|
2021
Q4 | $3.58M | Sell |
85,620
-1,621
| -2% | -$67.9K | 0.01% | 1107 |
|
|
2021
Q3 | $3.8M | Sell |
87,241
-23,088
| -21% | -$1M | 0.01% | 1031 |
|
|
2021
Q2 | $5.22M | Buy |
110,329
+20,901
| +23% | +$988K | 0.01% | 833 |
|
|
2021
Q1 | $4.58M | Sell |
89,428
-57,376
| -39% | -$2.94M | 0.01% | 829 |
|
|
2020
Q4 | $3.93M | Sell |
146,804
-514
| -0.3% | -$13.8K | 0.01% | 848 |
|
|
2020
Q3 | $5.06M | Sell |
147,318
-12,121
| -8% | -$416K | 0.02% | 641 |
|
|
2020
Q2 | $6.53M | Buy |
+159,439
| New | +$6.53M | 0.02% | 538 |
|